A carregar...
Apigenin and Abivertinib, a novel BTK inhibitor synergize to inhibit diffuse large B-cell lymphoma in vivo and vitro
Background: Apigenin, a flavonoid phytochemical extracted from fruits and vegetables, has shown anti-neoplastic effects in a variety of malignant tumors. DLBCL is the most common type of aggressive lymphoma in adults with a poor prognosis. Small-molecule inhibitors like BTK inhibitors have demonstra...
Na minha lista:
| Publicado no: | J Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7052937/ https://ncbi.nlm.nih.gov/pubmed/32127939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.34981 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|